Abstract
The focus of Startup R&R NOVABIO OCULAR is the research and development of therapeutic and diagnostic innovations (hard science) for posterior segment eye diseases. In Brazil, few pharmaceutical industries operate in this field. Our initial mission is age-related macular degeneration (AMD). AMD is the leading cause of blindness in individuals over 55 years of age, characterized by progres…